本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：601636 证券简称：旗滨集团 公告编号：2025-090 可转债代码：113047 可转债简称：旗滨转债 株洲旗滨集团股份有限公司 关于回购股份事项前十大股东和前十大无限售条件股东 持股情况的公告 2025 年 9 月 25 日，株洲旗滨集团股份有限公司（以下简称"公司"）召开 第六届董事会第五次会议，审议并通过了《关于以集中竞价交易方式回购股份的 议案》，具体情况详见《旗滨集团关于以集中竞价交易方式回购股份预案的公告》 （公告编号：2025-088）。 2、截至本公告披露日，公司的实际控制人俞其兵先生直接和间接持有（含 福建旗滨、俞勇及宁波旗滨投资有限公司）本公司股份数量共计 1,112,413,101 股，持股比例为 41.45%。实控人合计持股数量和比例没有发生变化。 特此公告。 株洲旗滨集团股份有限公司 二〇二五年九月三十日 序号 股东名称 持股情况 （股） 持股比例 （%） 1 福建旗滨集团有限公司 681,172,979 25.38 2 俞其兵 381, ...

①水泥：本周全国高标均价 351 元/t，同比-35 元/t，环比+5 元/t，全国平均出货率 46.5%，环比-1.9pct，库容比为 65.7%，环比+0.9pct，同比+0.3pct。②玻璃：本周浮法均价 1224.74 元/吨，环比上涨 16.79 元/吨，涨幅 1.39%，截 至 9 月 18 日重点监测省份生产企业库存天数约 26.18 天，较上周四减少 0.69 天。截至本周四，2.0mm 镀膜面板主流 订单价格 13 元/平方米左右，环比持平。③混凝土搅拌站：本周混凝土搅拌站产能利用率为 7.67%，环比+0.17pct。 ④玻纤：本周国内 2400tex 无碱缠绕直接纱均价 3524.75 元/吨，环比持平，电子布市场主流报价 4.1-4.2 元/米不 等，环比持平。⑤电解铝：美强劲数据打压美联储降息预期 铝价短期内震荡回升为主。⑥钢铁：钢材产量有所下降， 主要集中在螺纹钢产量下降较为明显。⑦其他：原油价格环比上涨，煤炭、有机硅、PE 价格环比下跌。 【重要变动】 ①9 月 25 日，中国巨石发布回购预案，拟以不超过 22 元/股回购不低于不低于 3,000 万股（含），不超过 4,000 ...

Overview - The laminated glass market in China is expected to reach a demand of 110.746 million square meters and a market size of 21.717 billion yuan in 2024, with a production volume of 157.651 million square meters [1][10] - The demand for laminated glass is driven by increasing national income levels and safety awareness, leading to its widespread application in construction and automotive sectors [1][10] Market Policies - The Chinese government has implemented various policies to support the development of the glass industry, including standards and guidelines aimed at promoting safety and sustainability [6] Industry Chain - The laminated glass industry chain includes upstream suppliers of raw materials like quartz sand and soda ash, midstream manufacturers of laminated glass, and downstream applications in construction, automotive, and other sectors [9] Current Market Situation - The construction sector accounts for nearly 50% of the laminated glass demand, with significant applications in residential, commercial, and public buildings [9][10] - The automotive sector is also a growing market for laminated glass, particularly with the rise of electric vehicles [10] Competitive Landscape - The laminated glass market in China is highly competitive, with domestic companies like Fuyao Glass, Xinyi Glass, and Flat Glass leading the market, achieving a domestic market share of 98.75% by 2024 [10][12] - Fuyao Glass reported a revenue of 21.450 billion yuan in the first half of 2025, with automotive glass accounting for 91.10% of its revenue [12] - Flat Glass achieved a revenue of 7.737 billion yuan in the same period, with a gross profit margin of 14.05% [12] Future Trends - The laminated glass industry is expected to see increased consolidation as smaller, less efficient companies are phased out due to stricter environmental standards [14] - The Belt and Road Initiative is anticipated to open new international markets for Chinese laminated glass companies, particularly in Southeast Asia and Africa [14]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 敬请广大投资者注意投资风险。 一、回购方案的基本情况 基于对株洲旗滨集团股份有限公司（以下简称"公司"）长期发展的坚定信心与内在价值的高度认可，为 切实维护投资者利益、提振市场信心，并建立健全长效激励约束机制，公司于2025年9月25日召开了第 六届董事会第五次会议，审议通过了《关于以集中竞价交易方式回购股份的议案》，同意公司使用自有 资金或自筹资金以集中竞价交易方式回购公司股份，在未来适宜时机用于员工持股计划或股权激励，回 购的资金总额不低于人民币10,000万元（含）且不超过20,000万元（含），具体回购股份的金额以回购 实施完毕或回购实施期限届满时回购股份实际使用的资金为准。回购价格不超过人民币9.00元/股 （含）。依照回购价格上限测算，回购的数量不低于1,100万股（含）且不超过2,200万股（含），最终 回购数量以回购期间实际使用的回购资金总额与实际回购价格确定；回购的期限为自董事会审议通过本 次回购股份预案之日起1 ...

Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]

证券日报网讯 9月26日晚间，旗滨集团发布公告称，近日，公司取得了中国工商银行股份有限公司湖南 省分行出具的《贷款承诺函》，工商银行湖南省分行承诺向旗滨集团提供回购股份专项贷款。《贷款承 诺函》主要内容如下：1、贷款金额：不超过人民币9，000万元；2、贷款期限：不超过三年；3、贷款 用途：专项用于回购公司股票。 （编辑 楚丽君） ...

Joint Ventures and Investments - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds a 51% stake [3] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao Biological Materials Co., a high-tech enterprise focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Cloning's equity to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Corporate Actions - New Sai Co. announced the resignation of its director and general manager, Chen Jianjiang, due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [8] - Zhejiang University Network New plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] Contracts and Orders - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase the company's profit by approximately 62.86 million yuan in 2025 [12] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [13] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for high-voltage energy storage systems [14] - ST Songfa's subsidiary signed contracts for the construction of four oil tankers, with a total contract value between 400 million to 600 million USD [15] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [16] Regulatory and Compliance - Jingliang Holdings received an administrative regulatory decision from Hainan Securities Regulatory Bureau for violations related to trade activities, involving an income amount of 299 million yuan [18] Shareholder Actions - Zaiseng Technology's controlling shareholder plans to reduce its stake by up to 3%, amounting to approximately 30.9 million shares [20] - Compton plans to reduce its repurchased shares by up to 1%, totaling approximately 2.5644 million shares [21] Financing Activities - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase from Industrial and Commercial Bank of China [23] - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [25]

Group 1 - Dongxing Medical plans to acquire 90% equity of Wuhan Yijiaobao for cash, which is expected to constitute a major asset restructuring [1] - Fosun Pharma's subsidiary plans to transfer 100% equity of Shanghai Cloning, with a transaction value of up to 1.256 billion yuan [1] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 400-600 million USD for four VLCCs, expected delivery between late 2026 and mid-2027 [3] - Qibin Group obtained financing support of up to 90 million yuan for share repurchase [4] Group 3 - Shapuaisi's shareholder plans to reduce holdings by up to 3% of the company's total shares [5] - *ST Kaixin intends to use up to 310 million yuan for cash management in safe and liquid financial products [6] Group 4 - Junchen Technology's shareholders plan to transfer 2.5% of the company's shares due to personal funding needs [7] - Jingliang Holdings received an administrative regulatory measure from Hainan Securities Regulatory Bureau for improper revenue recognition involving 299 million yuan [7] Group 5 - Tongcheng Holdings received a cash dividend of 24.6643 million yuan from Changsha Bank [9] - Shenyang Chemical appointed Chen Liguo as the new general manager [10] Group 6 - Huaguang Huaneng signed a contract for a 160 million yuan waste heat boiler project [15] - Shuxian Valley's subsidiary completed the re-registration of a health food product [16] Group 7 - Xuanta Pharmaceutical's new specification for a diabetes treatment drug was approved [17] - Panlong Pharmaceutical's application for a pain relief gel patch was accepted by the drug regulatory authority [18] Group 8 - Zhiguang Electric's subsidiary won a procurement contract worth 164 million yuan for a storage system [19] - Chitianhua's production facility resumed operations after maintenance [20] Group 9 - Haitong Development's application for a specific A-share issuance was accepted by the Shanghai Stock Exchange, aiming to raise 210 million yuan [20] - Risheng Technology's shareholders plan to transfer 4.02% of the company's shares [33] Group 10 - Pingmei Shares' controlling shareholder plans a strategic restructuring with Henan Energy Group [35] - Shenghui Integration's controlling shareholder committed not to reduce shareholdings for 12 months [37] Group 11 - Agricultural Bank and Bank of China will no longer establish supervisory boards, with their functions transferred to the audit committees [39][40] - Dongfang Yuhong's subsidiary signed a contract for a seawater pipeline project worth 2.524 billion USD [40][41] Group 12 - Ganfeng Lithium plans to introduce investors for a capital increase of up to 2.5 billion yuan [50] - Hanyu Pharmaceutical intends to raise up to 968 million yuan for various projects [51]

| 证券代码：601636 | 证券简称：旗滨集团 | 公告编号：2025-089 | | --- | --- | --- | | 可转债代码：113047 | 可转债简称：旗滨转债 | | 3、贷款用途：专项用于回购公司股票 株洲旗滨集团股份有限公司 关于取得金融机构股票回购专项贷款承诺函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、回购方案的基本情况 基于对株洲旗滨集团股份有限公司（以下简称"公司"）长期发展的坚定信 心与内在价值的高度认可，为切实维护投资者利益、提振市场信心，并建立健全 长效激励约束机制，公司于 2025 年 9 月 25 日召开了第六届董事会第五次会议， 审议通过了《关于以集中竞价交易方式回购股份的议案》，同意公司使用自有资 金或自筹资金以集中竞价交易方式回购公司股份，在未来适宜时机用于员工持股 计划或股权激励，回购的资金总额不低于人民币 10,000 万元（含）且不超过 20,000 万元（含），具体回购股份的金额以回购实施完毕或回购实施期限届满时回购股 份实际使用的资金为准。回购价格不 ...